Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer

Ghassan M Saed1, Rouba Ali-Fehmi, Zhong L Jiang

  • 1Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA. gsaed@med.wayne.edu

Gynecologic Oncology
|December 8, 2009
PubMed
Abstract

Insights

Myeloperoxidase (MPO) and inducible nitric oxide synthase (iNOS) drive cancer cell survival in epithelial ovarian cancer (EOC) by inhibiting apoptosis. Silencing MPO or iNOS boosts apoptosis, suggesting their potential as therapeutic targets.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Resistance to apoptosis is a hallmark of cancer, often regulated by S-nitrosylation.
  • Myeloperoxidase (MPO) and inducible nitric oxide synthase (iNOS) produce nitrosonium ions (NO(+)) that mediate S-nitrosylation.
  • Investigating MPO and iNOS in epithelial ovarian cancer (EOC) is crucial for understanding apoptosis regulation.

Purpose of the Study:

  • To investigate MPO and iNOS expression in EOC.
  • To determine the role of MPO and iNOS in regulating S-nitrosylation of caspase-3, its activity, and apoptosis in EOC.
  • To explore MPO and iNOS as potential therapeutic targets in EOC.

Main Methods:

  • Immunofluorescence was used to assess MPO and iNOS expression in EOC cell lines and tissues.
  • Gene silencing of MPO and iNOS was performed using siRNA.
  • Real-time RT-PCR, ELISA, and TUNEL assays were employed to evaluate S-nitrosylation, caspase-3 activity, and apoptosis.

Main Results:

  • MPO and iNOS were expressed in EOC cell lines and invasive EOC tissues, but not in normal ovarian epithelium.
  • Silencing MPO or iNOS decreased caspase-3 S-nitrosylation and increased caspase-3 activity and apoptosis.
  • Silencing MPO demonstrated a more significant effect on inducing apoptosis compared to silencing iNOS.

Conclusions:

  • MPO and iNOS are co-expressed in EOC cells and play a critical role in regulating apoptosis.
  • MPO and iNOS act as redox switches controlling apoptosis in EOC.
  • Targeting MPO and iNOS may offer novel diagnostic and therapeutic strategies for EOC.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.